Boenning & Scattergood Upgrades Xylem To Outperform

Analysts at Boenning & Scattergood upgraded

from Neutral to Outperform. The price target for Xylem is set to $40. Xylem shares have dropped 7.28% over the past 52 weeks, while the S&P 500 index has surged 9.36% in the same period. Xylem shares closed at $35.02 in pre-market trading.